Metabolic Response to Fat and Glucose

May 2, 2023 updated by: Rima Obeid, Universität des Saarlandes
The study will compare plasma and urine post-prandial metabolomics after fat and glucose oral load according to lifestyle factors.

Study Overview

Detailed Description

The metabolic response in plasma and urine, pre- and post-load tests in people with specific dietary lifestyles will be tested. This project will focus on fat and glucose induced changes of targeted metabolic pathways that have been related to diabetes and obesity risk.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Saarland
      • Homburg, Saarland, Germany, 66424
        • University of Saarland

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy volunteers
  • On a stable dietary habits

Exclusion Criteria:

  • Pregnancy
  • Malabsorption disorders
  • Present or former cancer
  • Any oral medication that affect glucose or fat absorptions
  • Cholesterol lowering drugs (i.e. Statins)
  • other drugs: fibrates, MTX, or vitamin supplements
  • Diabetes (type 1 and type 2)
  • Alcoholism
  • Weight losing diet during the last 4 months
  • Liver diseases
  • Renal dysfunction
  • Gastric resection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Glucose tolerance test
All participants will receive an oral standardized glucose tolerance test
Standardized oral glucose tolerance test (75 g oral glucose) and blood collection before and 2hrs after the glucose load
Other: Fat tolerance test
The same participants will receive an oral standardized fat load test
Oral fat tolerance will be provided to fasting participants and blood samples will be collected before and 4 hrs after the fat load.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Plasma levels of branched chain amino acid
Time Frame: Changes between baseline and 2 hours
Changes between baseline and 2 hours
Plasma Trimethylamin N-oxide
Time Frame: Changes between baseline and 2 hours
Changes between baseline and 2 hours
Plasma glucose level
Time Frame: Changes between baseline and 2 hours
Changes between baseline and 2 hours
Plasma glucose
Time Frame: Changes between baseline and 2 hours
Changes between baseline and 2 hours
Plasma level of acetyl-CoA
Time Frame: Changes between baseline and 2 hours
Changes between baseline and 2 hours

Secondary Outcome Measures

Outcome Measure
Time Frame
Plasma malonyl-CoA
Time Frame: Changes between baseline and 2 hours
Changes between baseline and 2 hours
Plasma phosphatidylcholine
Time Frame: Changes between baseline and 2 hours
Changes between baseline and 2 hours
Plasma insulin
Time Frame: Changes between baseline and 2 hours
Changes between baseline and 2 hours
Plasma leptin
Time Frame: Changes between baseline and 2 hours
Changes between baseline and 2 hours
Plasma Lactate
Time Frame: Changes between baseline and 2 hours
Changes between baseline and 2 hours
Plasma pyruvate
Time Frame: Changes between baseline and 2 hours
Changes between baseline and 2 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Rima Obeid, Universität des Saarlandes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 1, 2016

Primary Completion (Actual)

December 1, 2019

Study Completion (Actual)

June 1, 2020

Study Registration Dates

First Submitted

November 6, 2015

First Submitted That Met QC Criteria

November 10, 2015

First Posted (Estimate)

November 11, 2015

Study Record Updates

Last Update Posted (Estimate)

May 4, 2023

Last Update Submitted That Met QC Criteria

May 2, 2023

Last Verified

May 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • Postprandial metabolomics

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

will be decided at a later stage

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on Glucose tolerance test

Subscribe